SEC Form 4 · accession 0001140361-17-007729
BioRestorative Therapies, Inc. · BRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul Jude Tonna
Director
Period of report
Feb 14, 2017
Accepted (ET)
Feb 15, 2017 · 4:44 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001505497
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 6,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OptionF6,F2 | $5.70 | Feb 14, 2017 | D | 15,000 | D | — | Jun 27, 2024 | Common Stock | 15,000 | 0 | D |
| OptionF6,F2 | $4.70 | Feb 14, 2017 | A | 15,000 | A | — | Jun 27, 2024 | Common Stock | 15,000 | 15,000 | D |
| OptionF6,F3 | $6.60 | Feb 14, 2017 | D | 25,000 | D | — | Oct 23, 2024 | Common Stock | 25,000 | 0 | D |
| OptionF6,F3 | $4.70 | Feb 14, 2017 | A | 25,000 | A | — | Oct 23, 2024 | Common Stock | 25,000 | 25,000 | D |
| OptionF6,F4 | $7.00 | Feb 14, 2017 | D | 60,000 | D | — | Sep 4, 2025 | Common Stock | 60,000 | 0 | D |
| OptionF6,F4 | $4.70 | Feb 14, 2017 | A | 60,000 | A | — | Sep 4, 2025 | Common Stock | 60,000 | 60,000 | D |
| WarrantF1 | $15.00 | holding | — | — | — | Aug 1, 2014 | Jul 11, 2019 | Common Stock | 1,400 | 1,400 | D |
| WarrantF1 | $15.00 | holding | — | — | — | Aug 1, 2014 | Jul 31, 2019 | Common Stock | 100 | 100 | D |
| OptionF5 | $3.73 | holding | — | — | — | — | Jun 10, 2026 | Common Stock | 64,000 | 64,000 | D |
Explanation of responses
- F1Owned jointly with wife.
- F2The option vests to the extent of 5,000 shares on each of June 27, 2014, June 27, 2015 and June 27, 2016.
- F3The option is exercisable to the extent of 8,334 shares on October 23, 2015 and 8,333 shares on each of October 23, 2016 and October 23, 2017.
- F4The option is exercisable to the extent of 30,000 shares on December 22, 2015 and 10,000 shares on each of September 4, 2016, September 4, 2017 and September 4, 2018.
- F5The option is exercisable to the extent of 21,334 shares on June 10, 2016, and 21,333 shares on each of June 10, 2017 and June 10, 2018.
- F6The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price.